跳至主要内容
临床试验/ACTRN12618000283279
ACTRN12618000283279尚未招募4 期

A double blind, randomized, placebo controlled, cross-over trial investigating the effect of High Amylose Maize Starch (HAMS) supplementation on fecal microbiological and inflammatory outcomes in individuals with Cystic Fibrosis and Healthy Volunteers.

Mater Misericordiae Ltd0 个研究点目标入组 20 人开始时间: 2018年2月23日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 85 Years(—)
性别
All

入选标准

  • 未提供

排除标准

  • 未提供

研究者

相似试验

已完成
2 期
A double blind, randomized, placebo controlled, cross-over study to validate the predictive power of the demarcation formula for Lybrido and Lybridos efficacy in women with female sexual interest/arousal disorder, in the domestic situation.problems with sexual functioning10040480sexual dysfunction
NL-OMON40620Companion Diagnostics BV150
招募中
不适用
A study to validate the demarcation formula for Lybrido and LybridosFSIAD
NL-OMON28721Companion Diagnostics BV150
进行中(未招募)
不适用
ybrido(s) and SSRI's@home
EUCTR2013-001966-40-NLCompanion Diagnostics BV
进行中(未招募)
1 期
Trial on the effectiveness of Fampridine medication for upper limb function in people with MS.MedDRA version: 14.1Level: PTClassification code 10063401Term: Primary progressive multiple sclerosisSystem Organ Class: 10029205 - Nervous system disordersMultiple sclerosisMedDRA version: 14.1Level: PTClassification code 10053395Term: Progressive multiple sclerosisSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 14.1Level: PTClassification code 10063400Term: Secondary progressive multiple sclerosisSystem Organ Class: 10029205 - Nervous system disorders
EUCTR2011-002561-38-IESt. Vincent's University Hospital80
已完成
不适用
A double blind, placebo controlled, randomized, cross-over study to assess the effects of polydextrose on appetite suppression and its mechanisms of action in healthy women with a normal weight and overweight female participants10003018
NL-OMON41091TNO32